BR100 Decreased By (-0.91%)
BR30 Decreased By (-1.47%)
KSE100 Decreased By (-0.78%)
KSE30 Decreased By (-0.75%)
AGHA 6.67 Decreased By ▼ -0.01 (-0.15%)
BECO 4.35 Decreased By ▼ -0.02 (-0.46%)
BML 56.17 Decreased By ▼ -1.15 (-2.01%)
BOP 30.12 Decreased By ▼ -0.23 (-0.76%)
CNERGY 12.98 Decreased By ▼ -0.14 (-1.07%)
CSIL 5.31 Decreased By ▼ -0.10 (-1.85%)
FCCL 51.65 Decreased By ▼ -1.14 (-2.16%)
FFL 14.49 Decreased By ▼ -0.23 (-1.56%)
FNEL 1.21 Increased By ▲ 0.09 (8.04%)
KEL 6.06 Decreased By ▼ -0.03 (-0.49%)
KOSM 5.84 Increased By ▲ 0.11 (1.92%)
LOTCHEM 26.17 Decreased By ▼ -0.29 (-1.1%)
MLCF 91.23 Decreased By ▼ -1.93 (-2.07%)
NBP 164.19 Decreased By ▼ -0.47 (-0.29%)
NCPL 53.18 Decreased By ▼ -2.48 (-4.46%)
NPL 59.12 Decreased By ▼ -2.04 (-3.34%)
OGDC 313.39 Decreased By ▼ -3.34 (-1.05%)
PACE 9.77 Decreased By ▼ -0.10 (-1.01%)
PAEL 35.24 Decreased By ▼ -0.39 (-1.09%)
PIBTL 14.71 Increased By ▲ 0.03 (0.2%)
PPL 221.36 Decreased By ▼ -5.55 (-2.45%)
PRL 91.22 Decreased By ▼ -1.80 (-1.94%)
PTC 59.19 Decreased By ▼ -1.07 (-1.78%)
SSGC 23.30 Decreased By ▼ -0.51 (-2.14%)
TBL 8.75 No Change ▼ 0.00 (0%)
TELE 7.61 Decreased By ▼ -0.19 (-2.44%)
TPL 22.03 Decreased By ▼ -0.32 (-1.43%)
TPLP 12.56 Decreased By ▼ -0.41 (-3.16%)
TREET 21.73 Decreased By ▼ -0.43 (-1.94%)
TRG 55.79 Decreased By ▼ -0.77 (-1.36%)

ISLAMABAD: Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal, Tuesday, while stressing the need for eliminating counterfeit and substandard medicines, directed the Drug Regulatory Authority of Pakistan (DRAP) and other relevant departments to utilise all resources for the purpose.

The minister said this here while visiting the DRAP headquarters, saying that eliminating counterfeit and substandard medicines is essential for a healthier Pakistan.

The Minister for Health held a meeting with senior officials of DRAP including newly-appointed Chief Executive Officer Dr Obaidullah. The CEO DRAP briefed the federal minister on the institution’s functions, performance, and challenges.

While addressing the DRAP officers, Health Minister Kamal said that “Our decisions directly impact human lives and the outcomes of our decisions and actions should benefit the common man.”

In this respect, the minister directed, “the elimination of counterfeit and substandard medicines is imperative.”

“We must protect human lives from potential threats at all costs,” Kamal said. He said that “a coordinated strategy will be developed in collaboration with provincial governments to eliminate counterfeit medicines.”

“Pharmaceutical industries and local manufacturing should be facilitated and DRAP’s policies should be conducive to investment so that foreign manufacturing companies prioritise investing in Pakistan,” Kamal said.

The Federal Minister for Health emphasised increasing medicine exports by adopting international standards, adding that “the journey to elevate DRAP to WHO Level 4 should be accelerated.”

During the meeting, the minister further said that a National Medicine Policy will be formulated in consultations with all the stakeholders.

The DRAP officials in their briefing to the minister said DRAP in close collaboration with the federal health departments and provincial health authorities was using all available resources to check substandard medicines. The DRAP is also implementing Worlds Health Organization set rules and regulations on pharmaceutical industry, they informed the minister.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.